The breath diagnostics space is changing, Elizabeth
But is your CRM data an asset or a liability in finding clients like AstraZeneca and Cancer Research UK?
But is your CRM data an asset or a liability in finding clients like AstraZeneca and Cancer Research UK?
Most CRMs are a mess — full of outdated, messy, and duplicated data.
We clean it up.
Using Clay, AI, and custom rules, we enrich your records with precision.
The result?
Smarter segmentation, faster lead routing, and a CRM your team can finally trust.
No more guesswork. Just clean, accurate data.
Only a handful of sales leaders are using automated CRM enrichment. But those who do are getting a serious edge.
To help you explore how it might support your workflow, here are a few questions:
1️⃣ How do you currently prioritize which pharmaceutical research institutions to engage based on their diagnostic needs? 2️⃣ When assessing potential clients, how do you identify the key decision-makers involved in the procurement process? 3️⃣ What challenges do you face in ensuring that the data you rely on reflects the latest developments in biomarker research?
If you’re ready for a CRM that works for you, not against you, let’s talk.
The form has been successfully submitted.